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Summary: In recent years, there have been no new commercial developments in identification methods for the
clinical chemical laboratory. We are still faced, however, with the problem of ensuring accurate identification. By
using a model, the importance of reliable identification can be shown mathematically. The complete identification
of a sample is based on a five point identification statement. As a rule, appropriate measures are taken to abridge this
identification process, depending on the local situation. The terminology of identification processes is defined and
the presently available techniques are discussed.
Probleme der Identifikation im klinischen Laboratorium, Stand der Technik und weitere Überlegungen
Zusammenfassung: In den letzten Jahren wurden keine industriellen Neuentwicklungen für Identifikationsprozesse
im klinisch-chemischen Laboratorium angeboten. Die Schwierigkeiten der Identifikations-Sicherung bestehen aber
unverändert weiter. An einem Modell kann die Bedeutung der sicheren Identifikation rechnerisch belegt werden. Zur
vollständigen Probenidentifikation dient ein aus fünf Punkten zusammengesetztes Identifikations-Statement. Es
wird durch entsprechende Hilfsmittel und Maßnahmen in der Regel für innerbetriebliche Zwecke verkürzt. Die für
Identifikationsprozesse gebräuchlichen Begriffe werden definiert und die heute verfügbaren Techniken diskutiert.
Preliminary Remarks ' The importance of unequivocal identification in clinical
, _ j , j-rr- work is unquestionable. It must be possible to guarantee
Publications deaHng with the importance and the diffi- ^ f negative · Qr ̂  Q ̂ ^ are Mt
culties of identification processes m the> clinical chem- oduced by ̂ ^ in information transfer ̂  is Ae
istry laboratory are relatively few (1-6). Within the situation ̂  ̂  ^ m^.^ laboratorjes> where most
framework of scientific conferences, this theme was of ̂  results & ^ ̂  so_called normal fange? Qne
last discussed at the «Biochemische Analytik meeting ^ fayour ̂  yjew ̂  -t does not matter ,f ̂
in 1972 (7, 8), and in the same year in Munich at the ^^ proflles of two patients, both showing no
8th'World Pathology Congress (9). abnormalities, are interchanged. Since false identific-
A review of the present state of the technology reveals ation also includes re-exchange, the mistakes could even
that there have been no specific new developments in cancel themselves.
identification processes in the clinical chemical labor- ^^ dgspite Ae technical feasibility, longitudinal
atory in the last six years. All the currently used identif- observations are hardly ever carried out, there would
ication techniques were already known in 1972. appear to be a certain justification for this view.
The same applies to instrumentation. Product promotion
has claimed most attention, Whereas fundamental new
developments in instrumentation have only very
occasionally appeared, and there has been no willingness M0(jei systems
to exploit them.
Increasing interest has been shown in recent years in the
" ' use of the probability theory in medical diagnosis (10);
*) Revised from a paper given by the author at the international . i t . ,· j ,. ^ ,· r -j /r
nieeUng "ßSchemische Analytik 78" held in Munich on 18th »t may also be applied to the problem of sample identif-
to 21st Aprü 1978. ication. This is illustrated by the first example (fig. 1):
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Fig. l. Decision network; symbols:
K = patients
K = non-patients
T = positive test results
T = negative test result
J[ = correct identification
J = false identification
The doubly underlined numbers show the final result,
For further details, see the text.
give 480 correctly negative and 120 falsely positive
results. By wrong identification, a further 5 false
positives are now added, while 7 are changed back again
to correct negatives. There occur 48 identification errors
in the 480 true negatives, whereby 27 true negatives
remain, while 21 are changed to false positives. The
calculation of the probability that a re-exchange will
occur is shown in the example of the negative test results
(fig. 2). In summary, it can be ascertained that mistaken
identification leads to decrease in the number of true
positives, while the false negatives are increased. This
means that the sensitivity is effectively decreased from
0.8 to 0.77, and the specificity from 0.8 to 0.78.
If the prevalence is decreased to 0.1 (fig. 3), the sensiti-
vity decreases from 0.8 to 0.75, whereas the specificity
only decreases from 0.8 to 0.79,
This leads to the following conclusion: the lower the
prevalence of the disease in the collective, the more
serious is the effect of wrong identification on the
sensitivity of the test, In other words the charice of
identifying a clinically abnormal person in a collective
of many healthy individuals is further decreased.
We will take a collective of patients and healthy indi-
viduals; these are to be differentiated with the aid of a
single test, which simply yields a negative or positive
result. We will also assume that the prevalence of the
disease is 0.4, and the sensitivity and specificity are 0,8,
The certainty of identification is 0.9, so that in 100
samples 90 are identified correctly, but 10 are identified
wrongly.
The decision network shows the influence of insufficient
identification on the sensitivity of the te&t. Out of 400
patients, 320 show a correct positive test result, and 80
show a false negative result. These proportions are
altered yet again by the mistakes of identification. Thus,
of the 320 genuine positives, 288 are correct, and 32 are
wrongly identified, of the 80 false negatives, 72 are
correct and 8 are wrongly identified, For the 40 wrongly
identified samples, there are two further possibilities:
Faulty identification can lead to a positive or negative
test result. The 32 wrongly identified (but true positive)
samples now divide into 14 positive and 18 false nega-
tives. Of the 8 false negatives, 8 are wrongly identified,
and they then divide into 4 false? positives and 4 positives
which are now correct. The result is therefore 306
positives and 94 negatives. The binary test re^lt gives
no decision as to whether the correctly positive result
was obtained by a correct or false identification. The
analogous study, of the specificity, wjlich is likewise






Fig. 2. Calculation of the probability of a false identification





















Fig. 3. Decision network as in figure 1.
J. Clin. Chern. Clin. Biochem. / Vol. 17, 1979 / No. 2
Keller: Identification in the Clinical Laboratory 59
Definitions
Sample identification
The term sample identification (in the clinical chemical
laboratory) embraces all those processes and/or meas-
ures that serve to establish an identification statement
for a given quantity of test material from a patient.
Such a statement consists of the following five factors:
1. Source of the sample
As a rule, this is the name of the patient from whom
the sample was taken. This can be supplemented with
information that is useful for interpretation purposes:
age, sex, diagnosis/condition, therapeutic measures,
pretreatment before taking the sample, etc.
2. Source of the request
This is usually a doctor or clinic. Additional details
may include, for example, a request for communic-
ation of the results by telephone, or a requirement to
send the results to more than one person or institution,
etc.
3. Test material
It must be clear whether the material is serum, plasma
with additives, blood with or without additives, or
other test material with or without added foreign
substances.
4. Instructions
The instructions must consist of:
a) a statement of the required test or tests.
b) data required for the evaluation and calculation of
the results, e.g. 24-hour urine volume, or time of
blood sampling following glucose loading.
5. Timing
The following must be recorded:
a) the time or period of the day and the date that the
sample was taken from the patient.
b) The date and time that the material was received by
the laboratory.
This complete identification statement is necessary, if
the patient and test sample are separated in distance and
time from the laboratory and the analysis. The statement
must be made permanent, e.g. written by hand, or
recorded on a data carrier. An exception can be made, if
the investigation is carried out directly on the patient. For
example, if the patient is continually monitored by an
ECG machine (and the apparatus also records the time),
the identification statement can be omitted, identific-
ation processes are not required, and it is not even
necessary to know the name of the patient.
Direct sample identification
In direct sample identification, each specimen and each
process vessel can be described at any time in relation to
the identification statement. At every stage that involves
a measurement, the appropriate value is processed to-
gether with the corresponding identification in a data
set. Two basically different procedures are possible:
1. Direct sample identification without aids to identity
The sample container and identification statement are
kept together from the time of sampling to the con-
clusion of the analysis in the laboratory. The results
of all the measurements performed are entered on the
statement, so that they cannot be lost or confused.
Such conditions are, however, the exception. In
clinical laboratories this process is occasionally used
in the determination of blood gases: The sample
container is the syringe, containing the freshly
sampled arterial blood, and this is brought immediately
to the laboratory. Blood gases are then determined
accordingly in an ear-marked apparatus. The results
are written directly onto the accompanying statement
sheet; and they are often then communicated by
telephone.
2. Direct sample identification with aids to identity
In routine operation, the complete identity statement
is mostly too extensive and contains more information
than is required for the analytical processes. For this
reason, the statement is usually abbreviated, with the
aid of a code, to an identification symbol. This may
consist of a patient number, day number and/or other
relevant numbers, e.g. the nature of the test or tests
required.
Specimen vessels, process vessels and analytical records
are linked to one another by the identification symbols.
Retrieval of the complete identification statement
necessitates a decoding process, which may be based on,
for example, a "day list". Most simply, a manually
prepared list is used, while in better appointed labor-
atories, these lists are stored in an electronic data pro-
cessor (EDP).
Direct sample identification does not include the time,
place or nature of the identification process. Neither
does it guarantee that there is a positive link between
sample and measurement signal and/or result. In the
latter situation, i.e. if a EDP is installed and the identif-
ication is checked at every stage from the moment of
distribution to the production of the result, and if the
simultaneous mechanical transfer of the identification
symbol is compulsory at every transfer step, then the
procedure is justifiably called permanent identification,
a term introduced byEggstein (11).
When the specimen and process vessels can be identified,
by Virtue of carrying day numbers, patient numbers or
similar data, which are not, however, read visually or
mechanically at every working stage and processed with
the result, then the procedure can only be called partial
direct identification.
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Indirect sample identification
There are two variants of indirect identification: in
positional identification, the sample is identified from
its position in a chain of samples, a magazine, or sample
plate etc., which, in turn, is related to a list. Identif-
ication may take place, for example, by counting the
members of the chain, whereby regular empty spaces
act as markers. If only the order of samples, together
with a work list is used for identification, then the
procedure is called serial identification. This latter
method carries the greatest danger of sample interchange
in the laboratory.
A code is a syntactical working instruction. It shows, for
example, which position corresponds to a certain
number. The intellectual process of translating a several
digit number into a code is the coding; this is normally
performed mechanically. In any event, it is a process
that depends upon software. The corresponding hard-
ware counterpart performs the marking, e.g. the punching
of holes in a card. The holes punched in a particular
pattern are known as marks. Analogous processes are the
pencil-marking of labelling sheets, or the printing of
other information carriers, that serve for identification.
Although the definitions are clear, there is often a
failure, in english, to distinguish clearly between these
different procedures by use of the correct terminology.
The extent of influencing factors
Identification processes depend upon three factors:
1. The quantity of the specimen and the number of
different tests (range of the laboratory program).
2. Instrumentation and organisation of the operational
schedule.
3. Distance between laboratory and patient.
Each factor has a different effect on the nature and
scope of the identification process.
A general laboratory that processes 1000 samples per
day on five days of the week, and only uses a fixed
program on a multichannel analyser, can manage with
very simple identification procedures.
A small clinical laboratory may have a low degree of
mechanisation, but a large test program and discrimin-
ating analysis. It must therefore use a sample distribution
system, in which the identification processes function
just as smoothly as each subsequent analytical step. Here,
the question of patient admission may represent a serious
• problem. Patient admission is frequently an urgent
matter, yet test results without a corresponding set of
controls can lead to uncertainties.
A study of methods for the interpretation of instructions,
sample distribution and identification in the large
clinical laboratory, was recently published byKillian
(12), in which he employed the methods of operational
research. It is assumed that the samples arrive in the
laboratory in exponentially distributed intervals. In
addition, the laboratories always have a redundant range
of apparatus, i.e. the 20 most important tests can always
be performed on at least two different instruments. In
his model, Killian uses an adjoint matrix and develops
waiting queue-algorithms, which are based onPoisson-
distributed rates of arrival. The redundant instruments
are used in order to fulfill the optimal requirements for
economy and speed. Such complex distribution pro-
cesses, however, presuppose not only a functional EDP,
but an equally highly developed identification system.
This requires a much greater outlay for identification
purposes than in the first example.
The experience of recent years has shown the identif-
ication process within the laboratory depends essentially
upon the instrumentation. The central sample distri-
bution with central documentation which is still typic-
ally used in most clinical laboratories, is economically
inferior to the consecutive sample distribution and
documentation. Admittedly, central sample distribution
is not usually practised consistently in the clinical
laboratory. Some analysers are suited to a consecutive
distribution technique, e.g. the SMAC (Technicon), the
ACA (Du Pont), the GSAII (Greiner) and the PRISMA
(Clinicon), but their test programs alone are not sufficient
for the larger hospital laboratories. These large labor-
atories have to provide special system configurations to
meet special requirements (for example the determ-
ination of blood glucose), while at the same time
meeting the clinical requirements of a much larger test
program. Consecutive sample distribution, whose
identification process is determined by the available
analyser, cannot therefore be practised throughout the
laboratory. Also, many difficult analyses cannot be
completed in one day, so that identification must be
extended over a fairly long period. This considerably
increases the difficulty of ensuring the correctness of
the identification process.
A minimum of identification is necessary in bedside
analysis, or "monitoring". In the last six years, however,
the proportion of clinical-chemical bedside analyses has
remained low and unchanged.
Identification Techniques:
Various techniques are used for direct identification. The
most common of these are given in figure 4.
Eppendorf
The Eppendorf labelling system (13) is based on re-
flection marks^ that are imprinted on the process vessels,
In the completely planned laboratory, the required
analyses can be related to the availably apparatus at the
outset, and all the necessary process .vessels for one
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sample can be labelled at the mechanical sample distrib-
ution site. The marks, which are read automatically by
the machine, represent patient or day numbers, and they
correspond to a five channel binary code. They are
supplemented by visual characters, so that an operator
check is possible at any time. This particular identif-
ication system is widely used by laboratories in central
Europe.
SILAB
The SILAB-System represents a similar philosophy, but
it employs a different labelling technique (14, 15, 16).
The excellent reading-reliability of this system is un-
questionable. Unfortunately, the further development
and sale of this identification system have been dis-
continued.
Technicon
Label-reading by machine was realised by Technicon in
the IDEE-system (17, 18, 19), and it has been retained in
a modified form. This method is especially widely used
in Great Britain, but it is also popular in other European
laboratories.
IBM
Forerunner of this system was the IBM 1080 data
system with perforated punched cards which was intro-
duced by Rappoport (20, 21, 22) in the USA, and which
is still in use in many American and a few European
laboratories. There have been many interesting modific-
ations of the perforated punched card, e.g. by Borner
(23),Jentzsch (24) and others. The book „Diagnostik-
Informations-System" still offers many useful ideas and
suggestions (25); the situation up to 1975 has been
reported by Haeckel (26).
Bar code
Neady 10 years ago, Rubin (27) drew attention to the
Bar-code. Almost simultaneously, Dudek &Roka (28)
also reported satisfactory results with this labelling
system. Following a period of stagnation, renewed
interest is now being shown in this technique. In 1977,
Laue (29) reported detailed studies with the Bar-code:
the identification labels are not restricted to any one
kind of vessel; in addition to specimen tubes, they can
also be used for haematocrit capillaries, urine vessels,
blood sugar tubes etc. Labels and analysis requests carry
the Bar-code label, but they can also be read visually. It
appears that the success of this system is due to the fact
that the reading process is especially simple; it can be
performed rapidly and reliably, either manually with
the aid of a reading pistol, or mechanically with a laser
beam. It should be pointed out that the reading unit,
which is required in order to achieve high reading reli-
ability, is relatively cheap. With the aid of the EDP, Bar-
code labels are produced for the primary serum vessel
and for all the other necessary process vessels. These
labels carry the identification number of the patient,
together with the requested type of investigation. Ex-
perience has shown that the reading reliability is not
endangered even by badly smudged labels. The system
has, however, the following disadvantages:
1. The labels are so large that they cannot be stuck onto
microlitre vessels.
2. The durability of the marking instruments is limited,
and
3. The label printers have a relatively high rate of break-
down and they are expensive.
American blood banks were recently recommended by
the American Blood Commission (30) to label all blood
storage vessels with Bar-code labels, and to introduce
the CODABAR reading system. It is to be expected that
this type of identification, at least in the USA, will soon
be used very widely. Meanwhile, Technicon have fitted
their blood group analyser with a Bar-code-laser-scanner
(fig. 5). Reading by the laser beam requires no contact
with the label; the labels can also be read at an angle,
and they can even be stuck in a slanting position on the
sample. The Bar-code system has also been fitted into
two large analysers, which are so far in the prototype
stage, namely the Hycel M and the PRISMA (Clinicon).
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Fig. 5. Prototype for reading
Bar-code with the aid
of a Laser beam.
OCR
The most recent and perhaps most promising develop-
ment is optical character recognition (OCR) (31). Op-
tional character sets for OCR at present in common use
for single scanners are shown in figure 6. Provisionally,
it is possible to read every digit, although a more
economically priced reading apparatus will limit the
reading ability to the first 10 letters. Operation of the
reading pistol, shown here for the Eppendorf ELIS
system, is extremely simple. Its error-free and relatively
quick use comes easily to the hands of even non-
specialised personel (fig. 7).



































































































Fig. 6. Optional character sets for OCR.
OCR has the following advantages:
1. OCR is a direct code, and the information can be read
both automatically and visually.
2. No special printing apparatus is needed; the labels
and other information carriers can be prepared for
OCR with any golf-ball typewriter, or EDP-controlled
rapid printer.
3. In the forseeable future, OCR systems will be able to
read automatically the name of the patient and other
alpha-numerical information.
4. OCR labelling and reading are becoming increasingly
popular in the commercial field. Further development
should therefore be accelerated, and the prices of the
reading apparatus should come down.
5. The central institute for contributory health insurance
("kassen rztliche Versorgung") in the German Federal
Republic has developed a method for assessing
medical services, which is also based on the OCR '
system (32). This could also contribute to decreasing
the costs and to shortening the time for development.
Disadvantages of the simple OCR reader at the
moment are the limited number of symbols and the
relatively slow manual operation of the reading pistol.
In big laboratories, where several hundred samples
must be read in a short time, a scanner for mark-
sense cards is at present essential.
Others
The following two possibilities for sample identification
have seen no further development:
The coded cap, planned for the SILAB system (33),
acted as a seal for the specimen vessel, arid its edge .
represented a ring-type, five channel -system of strip
holes. It carried data for patient number, process number
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and/or the requested analytical method, and it served as
the information basis for the sample distributer. The
failure to adopt this elegant and imaginative concept
was certainly to a large extent due to economic con-
siderations.
Another original concept was the magnetic collar
described by Grabner et al (34) in 1974. This consisted
of an identification ring containing six steel wires, which
could be magnetised to give an 18-bit information
system. Static reading was by the Hall effect. Unfortun-
ately this system also found no acceptance. Equally
unsuccessful were the magnetic caps fitted to the Mark
X 10 produced by the firm Hycel.
Final Observations
From the foregoing discussion, it is clear that in all
methods presently employed, it is not the material under
investigation that is identified with respect to the source
of the material but the sample container and/or chain of
containers. The source of material and the corresponding
analytical results can only be related by a reconstruction
process. Thus the weakest link in the identification chain
is revealed: The unequivocal identification of the patient
and the reliable initial transfer of the patient identif-
ication to the specimen (i.e. specimen-vessel). None of
the suggestions for the improvement of the reliability of
this decisive step, e.g. an identification carrier per-
manently associated with each patient, has found wider
application (35). Whenever the taking or collection of
samples is not performed by laboratory personel, all
further efforts to ensure correct identification are
fraught, from the outset, with a non-calculable un-
certainty factor.
In summary, it must be said that in the last six years,
there has been no significant progress in the field of
identification of patient, specimen or process vessel;
although most large laboratories now have some form
of electronic data processing. The expectation, that the
introduction of EDP's would greatly influence the
identification process, has not been fulfilled.
The Bar-code or the OCR system appear to have the
best chances for the future. With both systems, how-
ever, there are still certain technical difficulties and as
yet there is no sign that these will be overcome.
At the present time, it is therefore not possible to make
general, firm recommendations for identification
systems in clinical chemical laboratories. In the absence
of any alternative for ensuring the reliability of every
identification process, the stability of the operation and
organisation of the laboratory will always be crucial.
Together with manifold technical and scientific aids,
moderation, accuracy and self criticism remain, now as
ever, the most important parameters in our laboratories;
indeed they are more important in the patient
identification process.
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